glp-1 side effects depression Part 2 of a 3-Part Series; Medications for Weight Loss Doctors and patients across social

Efficacy magnitude Clinical trials show GLP-1 agonists produce substantial HbA1c reductions (typically 1.01.5% depending on agent and dose) and weight loss (515% of body weight with higher doses)

Patients in participating plans would pay something like the current Bridge copay, but the cost would shift from the federal government to the insurer

Bone 43 (1), 135139

Some of Novos reports, the inspection report noted, were more than 800 days late

Thirty-four reported adverse effects, including hypersensitivity, injection-site reactions, pruritus, urticaria, angioedema, and immune-mediated conditions like bullous pemphigoid